Antiseizure medications for post‐stroke epilepsy: A real‐world prospective cohort study
Tomotaka Tanaka(Shimane University), Kazuki Fukuma(Kyoto University), Soichiro Matsubara(Kumamoto University), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Naruhiko Kamogawa(National Cerebral and Cardiovascular Center), Yasuhiro Manabe(National Hospital Organization), Shigeo Murayama(Tokyo Metropolitan Institute of Gerontology), Masahiro Mizobuchi(Sapporo Minami Hospital), Riki Matsumoto(Kobe University), Junichiro Suzuki(Wakunaga (Japan)), Rie Motoyama(National Cerebral and Cardiovascular Center), Daisuke Onozuka(National Cerebral and Cardiovascular Center), Masafumi Ihara(Kyoto University), Masatoshi Koga(National Cerebral and Cardiovascular Center), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Hiroyuki Ishiyama(National Cerebral and Cardiovascular Center), Soichiro Abe(National Cerebral and Cardiovascular Center), Akio Ikeda(Kyoto University), Akihiro Shimotake(Kyoto University), Hajime Yoshimura(Kobe City Medical Center General Hospital), Ryōsuke Takahashi(Kyoto University), Katsuya Kobayashi(Kyoto University), Shuhei Ikeda(National Cerebral and Cardiovascular Center), Takayuki Matsuki(St Mary's Hospital)
Cited by 39
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Structure-based classification of tauopathies
|Nature|2021|916
Structures of α-synuclein filaments from multiple system atrophy
|Nature|2020|830
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|809